Phio Pharmaceuticals Corp. of KING OF PRUSSIA, PA, a company, filed a Form D amendment with the SEC on 2018-08-17. The offering totals $15.3M, of which $1.9M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 30 people.
| Name | Role | Location |
|---|---|---|
| Robert Bitterman | Director | Marlborough, MA |
| Keith Brownlie | Director | Marlborough, MA |
| Paul Dorman | Director | Marlborough, MA |
| Jonathan Freeman | Director | Marlborough, MA |
| Curtis Lockshin | Director | Framingham, MA |
| Geert Cauwenbergh | Executive Officer | Marlborough, MA |
| Curtis A Lockshin, Ph.D. | Director | King of Prussia, PA |
| Lisa H Carson | Executive Officer | King of Prussia, PA |
| David H Deming | Director | King of Prussia, PA |
| Jonathan A Freeman | Director | King of Prussia, PA |
| Lisa A Carson | Executive Officer | KING OF PRUSSIA, PA |
| Robert A Infarinato | Executive Officer | Marlborough, MA |
| Robert A Infarinato | Promoter | Marlborough, MA |
| Patricia A Bradford | Director | Marlborough, MA |
| Robert J Bitterman | Director | Marlborough, MA |
| Robert J Bitterman | Executive Officer | Marlborough, MA |
| Geert A Cauwenbergh | Director | Marlborough, MA |
| Jonathan E Freeman | Director | Marlborough, MA |
| Robert L Ferrara | Director | Marlborough, MA |
| Curtis A Lockshin | Director | Marlborough, MA |
| Gerrit Dispersyn | Director | Marlborough, MA |
| Gerrit Dispersyn | Executive Officer | Marlborough, MA |
| Caitlin Kontulis | Executive Officer | Marlborough, MA |
| Geert Cauwenbergh | Director | Marlborough, MA |
| H Paul Dorman | Director | Marlborough, MA |
Showing 15 of 17 filings.
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-11-12 | D | $25.9M | $1.4M |
| 2025-08-04 | D | $5.1M | $232K |
| 2025-01-28 | D | $3.7M | $153K |
| 2025-01-28 | D | $5.0M | $208K |
| 2025-01-28 | D | $6.4M | $266K |
| 2025-01-07 | D | $480K | $30K |
| 2025-01-03 | D | $1.3M | $55K |
| 2024-07-24 | D | $6.4M | $136K |
| 2023-12-19 | D | $5.4M | $533K |
| 2023-06-13 | D | $10.9M | $3.0M |
| 2023-05-02 | D | $4.0M | $4.0M |
| 2022-11-23 | D | $2K | $2K |
| 2021-02-16 | D | $24.3M | $14.0M |
| 2020-04-14 | D | $4.4M | $4.4M |
| 2020-02-24 | D | $1.9M | $1.9M |